FI891710A0 - Menetelmä kedarsidiini-antibiootin valmistamiseksi - Google Patents

Menetelmä kedarsidiini-antibiootin valmistamiseksi

Info

Publication number
FI891710A0
FI891710A0 FI891710A FI891710A FI891710A0 FI 891710 A0 FI891710 A0 FI 891710A0 FI 891710 A FI891710 A FI 891710A FI 891710 A FI891710 A FI 891710A FI 891710 A0 FI891710 A0 FI 891710A0
Authority
FI
Finland
Prior art keywords
kedarcidin
antibiotics
preparation
protein
streptoalloteichus
Prior art date
Application number
FI891710A
Other languages
English (en)
Swedish (sv)
Other versions
FI93969B (fi
FI93969C (fi
FI891710L (fi
Inventor
Sandra J Hofstead
James Andrew Matson
Kin Sing Lam
Salvatore Forenza
James A Bush
Koji Tomita
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI891710A0 publication Critical patent/FI891710A0/fi
Publication of FI891710L publication Critical patent/FI891710L/fi
Publication of FI93969B publication Critical patent/FI93969B/fi
Application granted granted Critical
Publication of FI93969C publication Critical patent/FI93969C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
FI891710A 1988-04-12 1989-04-11 Menetelmä kedarsidiini-antibiootin valmistamiseksi FI93969C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US18051988 1988-04-12
US32300189 1989-03-17
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin

Publications (4)

Publication Number Publication Date
FI891710A0 true FI891710A0 (fi) 1989-04-11
FI891710L FI891710L (fi) 1989-10-13
FI93969B FI93969B (fi) 1995-03-15
FI93969C FI93969C (fi) 1995-06-26

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891710A FI93969C (fi) 1988-04-12 1989-04-11 Menetelmä kedarsidiini-antibiootin valmistamiseksi

Country Status (24)

Country Link
US (1) US5001112A (fi)
EP (1) EP0337430B1 (fi)
JP (1) JP2850132B2 (fi)
KR (1) KR970010137B1 (fi)
CN (1) CN1034589C (fi)
AT (1) ATE101653T1 (fi)
AU (1) AU623641B2 (fi)
CA (1) CA1338262C (fi)
CY (1) CY1849A (fi)
DE (1) DE68913063T2 (fi)
DK (1) DK174751B1 (fi)
ES (1) ES2061760T3 (fi)
FI (1) FI93969C (fi)
HK (1) HK83195A (fi)
HU (1) HU201119B (fi)
IE (1) IE62912B1 (fi)
IL (1) IL89896A0 (fi)
MY (1) MY105842A (fi)
NO (1) NO174474C (fi)
NZ (1) NZ228672A (fi)
PL (1) PL161004B1 (fi)
PT (1) PT90252B (fi)
SG (1) SG30654G (fi)
YU (1) YU73989A (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
US20030180766A1 (en) * 2002-01-24 2003-09-25 Ecopia Biosciences, Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
CA2777837C (en) * 2008-10-27 2017-07-11 Novartis Ag Purification method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (fi) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
KR900016469A (ko) 1990-11-13
PL161004B1 (pl) 1993-05-31
YU73989A (en) 1991-04-30
DK173589A (da) 1989-10-13
JP2850132B2 (ja) 1999-01-27
US5001112A (en) 1991-03-19
CA1338262C (en) 1996-04-23
NO174474C (no) 1998-06-09
JPH01317396A (ja) 1989-12-22
HU201119B (en) 1990-09-28
CN1037735A (zh) 1989-12-06
NO891462L (no) 1989-10-13
DE68913063T2 (de) 1994-06-09
EP0337430B1 (en) 1994-02-16
KR970010137B1 (ko) 1997-06-21
IE891157L (en) 1989-10-12
PT90252A (pt) 1989-11-10
IE62912B1 (en) 1995-03-08
PL278782A1 (en) 1989-12-27
NZ228672A (en) 1990-07-26
EP0337430A2 (en) 1989-10-18
DK174751B1 (da) 2003-10-20
IL89896A0 (en) 1989-12-15
FI93969B (fi) 1995-03-15
ES2061760T3 (es) 1994-12-16
HK83195A (en) 1995-06-01
MY105842A (en) 1995-01-30
SG30654G (en) 1995-09-01
DE68913063D1 (de) 1994-03-24
EP0337430A3 (en) 1991-07-24
ATE101653T1 (de) 1994-03-15
FI93969C (fi) 1995-06-26
HUT50880A (en) 1990-03-28
FI891710L (fi) 1989-10-13
AU3272889A (en) 1989-10-19
CY1849A (en) 1996-03-08
PT90252B (pt) 1994-07-29
NO174474B (no) 1994-01-31
CN1034589C (zh) 1997-04-16
DK173589D0 (da) 1989-04-11
AU623641B2 (en) 1992-05-21
NO891462D0 (no) 1989-04-10

Similar Documents

Publication Publication Date Title
WO1989009788A3 (en) Biosynthetic osteogenic proteins and osteogenic devices containing them
AU565479B2 (en) Simultaneous production of two or more gene products
AU6502986A (en) Human lysozyme
AU643959B2 (en) Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
DE58908428D1 (de) Sekretormutante von Escherichia coli.
FI891710A0 (fi) Menetelmä kedarsidiini-antibiootin valmistamiseksi
AU7662387A (en) Novel substrate peptides
ES2018734A6 (es) Procedimiento para la obtencion de un enzima proteolitico.
AU1704988A (en) Peptide production by protein engineering
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
MY110997A (en) Novel aminopeptidase, processes for the preparation of aminipeptidase and protien therefrom
AU3810389A (en) Process for extracting and purifying epidermin
EP0322717A3 (en) Dactylocycline a and dactylocycline b

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BRISTOL-MYERS SQUIBB COMPANY

MA Patent expired